Chlorine in PDB 6vn5: USP7 in Complex with Ligand Compound 7

All present enzymatic activity of USP7 in Complex with Ligand Compound 7:
3.4.19.12;

The structure of USP7 in Complex with Ligand Compound 7, PDB code: 6vn5 was solved by P.R.Leger, D.J.Wustrow, D.X.Hu, S.Krapp, K.Maskos, M.Blaesse, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	47.80 / 2.90
Space group	P 1 21 1
Cell size a, b, c (Å), α, β, γ (°)	70.430, 65.078, 85.189, 90.00, 93.58, 90.00
R / Rfree (%)	21.4 / 26.8

The binding sites of Chlorine atom in the USP7 in Complex with Ligand Compound 7 (pdb code 6vn5). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the USP7 in Complex with Ligand Compound 7, PDB code: 6vn5:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in the USP7 in Complex with Ligand Compound 7


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of USP7 in Complex with Ligand Compound 7 within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl601 b:76.9 occ:1.00 CL11 A:R41601 0.0 76.9 1.0 C10 A:R41601 1.7 85.1 1.0 C9 A:R41601 2.7 80.8 1.0 C12 A:R41601 2.7 89.3 1.0 CD A:ARG408 3.7 90.5 1.0 CE A:LYS420 3.7 0.5 1.0 C8 A:R41601 4.0 82.9 1.0 C13 A:R41601 4.0 95.6 1.0 CB A:HIS456 4.1 79.7 1.0 CB A:ARG408 4.1 88.2 1.0 ND1 A:HIS456 4.2 91.1 1.0 CB A:ASN512 4.2 90.8 1.0 CB A:TYR514 4.3 65.3 1.0 NZ A:LYS420 4.3 0.9 1.0 CG A:ARG408 4.4 86.2 1.0 O A:ASN512 4.4 90.7 1.0 ND2 A:ASN512 4.5 98.7 1.0 CG A:HIS456 4.5 85.3 1.0 C17 A:R41601 4.5 93.5 1.0 CD A:LYS420 4.7 0.6 1.0 CD2 A:TYR514 4.8 66.6 1.0 CE2 A:PHE409 4.8 94.2 1.0 NE A:ARG408 4.8 96.3 1.0 CG A:TYR514 4.9 63.7 1.0 CG A:ASN512 4.9 96.9 1.0

Chlorine binding site 2 out of 2 in the USP7 in Complex with Ligand Compound 7


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of USP7 in Complex with Ligand Compound 7 within 5.0Å range: probe atom residue distance (Å) B Occ B:Cl601 b:74.7 occ:1.00 CL11 B:R41601 0.0 74.7 1.0 C10 B:R41601 1.7 68.4 1.0 C9 B:R41601 2.7 74.5 1.0 C12 B:R41601 2.7 73.7 1.0 CD B:ARG408 3.6 75.2 1.0 CE B:LYS420 3.8 85.9 0.0 OD1 B:ASN512 3.9 0.4 1.0 C8 B:R41601 4.0 80.7 1.0 C13 B:R41601 4.0 80.7 1.0 CB B:ARG408 4.0 79.3 1.0 CB B:TYR514 4.2 59.4 1.0 CB B:HIS456 4.2 70.8 1.0 CG B:ASN512 4.2 99.4 1.0 ND1 B:HIS456 4.3 75.8 1.0 ND2 B:ASN512 4.3 96.1 1.0 CG B:ARG408 4.4 74.4 1.0 NZ B:LYS420 4.4 87.2 0.0 C17 B:R41601 4.5 84.2 1.0 O B:ASN512 4.6 78.0 1.0 CG B:HIS456 4.6 72.9 1.0 CD B:LYS420 4.7 91.5 1.0 CE2 B:PHE409 4.7 0.3 1.0 CD2 B:TYR514 4.7 60.4 1.0 NE B:ARG408 4.8 78.0 1.0 CG B:TYR514 4.8 59.9 1.0

P.R.Leger, D.X.Hu, B.Biannic, M.Bui, X.Han, E.Karbarz, J.Maung, A.Okano, M.Osipov, G.M.Shibuya, K.Young, C.Higgs, B.Abraham, D.Bradford, C.Cho, C.Colas, S.Jacobson, Y.M.Ohol, D.Pookot, P.Rana, J.Sanchez, N.Shah, M.Sun, S.Wong, D.G.Brockstedt, P.D.Kassner, J.B.Schwarz, D.J.Wustrow. Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with in Vivo Anti-Tumor Activity. J.Med.Chem. 2020.
ISSN: ISSN 0022-2623
PubMed: 32302140
DOI: 10.1021/ACS.JMEDCHEM.0C00245